Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes | Zendy

Daniëlle A.M. Heideman | Zendy; Albertus T. Hesselink | Zendy; Johannes Berkhof | Zendy; Folkert J. van Kemenade | Zendy; Willem J. G. Melchers | Zendy; Nathalie Fransen Daalmeijer | Zendy; Muriël C.G.T. Verkuijten | Zendy; Chris J.L.M. Meijer | Zendy; Peter J.F. Snijders | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

Author(s) -

Daniëlle A.M. Heideman,

Albertus T. Hesselink,

Johannes Berkhof,

Folkert J. van Kemenade,

Willem J. G. Melchers,

Nathalie Fransen Daalmeijer,

Muriël C.G.T. Verkuijten,

Chris J.L.M. Meijer,

Peter J.F. Snijders

Publication year - 2011

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.05552-11

Subject(s) - cervical screening , medicine , test (biology) , virology , cervical cancer , biology , paleontology , cancer

This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research